P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UN...

por Delicou, S., Triantafyllou, M., Xydaki, A., Savvidis, C., Aggeli, K., Koskinas, I.
Publicado 2022

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE

por Xydaki, A.X., Kotsiafti, A.K., Manganas, K.M., Paraskeva, A.P., Pavlou Efthimia, E.P., Politis Konstantina, K.P., Delicou, S.D.
Publicado 2023

P130: PROVIDING ADEQUATE HEALTHCARE TO PEOPLE WITH HEMOGLOBINOPATHIES DURING THE PANDEMIC (COVID-19)

por Sophia Delicou, S, Aikaterini Xydaki, A, Konstantinos Manganas, K, Lucia Evliati, L, Chrysoula Kalkana, C, Michael Diamantidis, M, Achilles Manafas, A, Marianna Katsatou, M, Leonidas Roumpatis, L, Theodoros Aforozis, T
Publicado 2022

P1506: REAL-WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

por Delaporta, P., Delicou, S., Kouraklis-Symeonidis, A., Diamantidis, M., Vlachaki, E., Xydaki, A., Labropoulou, V., Lazaris, V., Michalitsis, M., Klonizakis, P., Toutoudaki, K., Chatzieleftheriou, M.-I., Kyriakopoulou, D., Kattamis, A.
Publicado 2022